IndraLab

Statements

CACNA1A activates episodic ataxia type II. 1 / 1

| 1

reach

"On the other hand, episodic ataxia type II is caused most often by the mutation in calcium channel gene CACNA1A, but potassium channel blocker - 4-amino pyridine, is one of the efficient treatment option [XREF_BIBR]."

23409712

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CACNA1A activates episodic ataxia type II. 1 / 1

INDRA sources:

Databases

Reading